Kapidex Approval History

• FDA approved: Yes (First approved January 30th, 2009)
• Brand name: Kapidex
• Generic name: dexlansoprazole
• Previous name: TAK-390MR
• Company: Takeda Pharmaceutical Company Limited
• Treatment for: Erosive Esophagitis, GERD

Kapidex (dexlansoprazole) is a proton pump inhibitor with a novel delivery system approved for the treatment of erosive esophagitis and heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD).

FDA Approval History for Kapidex

Date	Article
Feb  2, 2009	FDA Approves Kapidex (dexlansoprazole) for the Treatment of GERD
Oct 20, 2008	FDA Adds Three Months to Review of Takeda's New Drug Application for TAK-390MR
Jan  4, 2008	TAP Pharmaceutical Products Inc. Files New Drug Application for TAK-390MR in Patients with Acid-Related Disorders

See also...

Kapidex (dexlansoprazole) Consumer Information

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.